Matrix Metalloproteinase‐3 Genotype Contributes to Age‐Related Aortic Stiffening Through Modulation of Gene and Protein Expression

Abstract —Matrix metalloproteinases (MMPs) include most major constituents of the arterial wall as substrates. A common promotor polymorphism (5A/6A) is associated with differences in MMP‐3 (stromelysin‐1) activity, and associations with certain forms of vascular disease have been shown. This study investigated whether the MMP‐3 5A/6A promoter polymorphism contributes to age‐related large artery stiffening. MMP‐3 5A/6A genotype was determined in 203 (135 male) low cardiovascular risk, unmedicated individuals who were divided prospectively into two groups (30 to 60 years, n=126; ≥61 years, n=77). Noninvasive large artery stiffness was measured as ascending aortic input impedance from brachial blood pressure, carotid tonometry, and Doppler ascending aortic blood flow. In the older group, homozygotes had higher aortic input (P<0.01) and characteristic (P<0.01) impedance, ie, higher stiffness, than heterozygotes after correction for the effects of age, gender, and mean arterial pressure. There was no such difference in the younger group. Gene expression was subsequently investigated in dermal biopsies in randomly selected older men from the same cohort with real‐time PCR (n=40). In 5A homozygotes, gene expression was 4‐fold higher (P<0.05), and in 6A homozygotes, 2‐fold lower (P<0.05) compared with the heterozygotes. Differences in gene expression were associated with corresponding significant changes in MMP‐3 protein levels. Concordance between dermal and aortic gene and protein expression was shown in a separate cohort of postmortem aortic samples (n=7). We conclude that MMP‐3 genotype may be an important determinant of vascular remodeling and age‐related arterial stiffening, with the heterozygote having the optimal balance between matrix accumulation and deposition. (Circ Res. 2003;92:1254–1261.)

[1]  A. Henney,et al.  Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. , 1994, British heart journal.

[2]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[3]  M. Bendeck.  Matrix metalloproteinases: are they antiatherogenic but proaneurysmal? , 2002, Circulation research.

[4]  J. Staessen,et al.  Carotid and Femoral Artery Stiffness in Relation to Three Candidate Genes in a White Population , 2001, Hypertension.

[5]  R. E. Luna,et al.  Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. , 1998, Circulation.

[6]  P. Libby,et al.  Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. , 1997, Circulation.

[7]  A. Dart,et al.  Aortic distensibility and left ventricular structure and function in isolated systolic hypertension. , 1993, European heart journal.

[8]  C H Chen,et al.  Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. , 1996, Hypertension.

[9]  M. E. Safar,et al.  Aortic Pulse Wave Velocity Predicts Cardiovascular Mortality in Subjects >70 Years of Age , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[10]  Y. Sugishita,et al.  Coronary circulation in dogs with an experimental decrease in aortic compliance. , 1993, Journal of the American College of Cardiology.

[11]  G. Murphy,et al.  Physiological mechanisms for metalloproteinase activation. , 1992, Matrix (Stuttgart, Germany). Supplement.

[12]  D. Kass,et al.  Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker , 2001, Circulation.

[13]  C. Bouchard,et al.  Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[14]  R. Jeremy,et al.  Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. , 1994, The American journal of cardiology.

[15]  Alberto Smith,et al.  Stromelysin-1 (Matrix Metalloproteinase-3) and Tissue Inhibitor of Metalloproteinase-3 Are Overexpressed in the Wall of Abdominal Aortic Aneurysms , 2002, Circulation.

[16]  C. Iwai,et al.  Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. , 1999, Circulation.

[17]  A. Dart,et al.  Pulse pressure--a review of mechanisms and clinical relevance. , 2001, Journal of the American College of Cardiology.

[18]  D. Levy,et al.  Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.

[19]  J Kachaner,et al.  Mechanical properties of the common carotid artery in Williams syndrome , 2000, Heart.

[20]  E E van der Wall,et al.  The influence of aging and aortic stiffness on permanent dilation and breaking stress of the thoracic descending aorta. , 1999, Cardiovascular research.

[21]  Bronwyn A Kingwell,et al.  Fibrillin-1 Genotype Is Associated With Aortic Stiffness and Disease Severity in Patients With Coronary Artery Disease , 2002, Circulation.

[22]  R. Rucker,et al.  Structure and metabolism of arterial elastin. , 1977, International review of experimental pathology.

[23]  H. Kuivaniemi,et al.  Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. , 1999, Biochemical and biophysical research communications.

[24]  A P Avolio,et al.  Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. , 1983, Circulation.

[25]  D. Collen,et al.  Reduced Atherosclerotic Plaque but Enhanced Aneurysm Formation in Mice With Inactivation of the Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Gene , 2002, Circulation research.

[26]  A. Dart,et al.  Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample. , 1998, Hypertension.

[27]  W. Nichols,et al.  McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles , 1998 .

[28]  James D Cameron,et al.  Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. , 2002, Journal of the American College of Cardiology.

[29]  T. Shoji,et al.  Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. , 1999, Diabetes care.

[30]  M Zidi,et al.  Compressibility of the Carotid Artery in Patients With Pseudoxanthoma Elasticum , 2001, Hypertension.

[31]  J. Woessner,et al.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  F. Cambien,et al.  Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. , 1996, Circulation.

[33]  M. Biondi,et al.  Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Promoter Polymorphisms Are Associated With Carotid Artery Stenosis , 2002, Stroke.

[34]  A. Henney,et al.  Progression of Coronary Atherosclerosis Is Associated with a Common Genetic Variant of the Human Stromelysin-1 Promoter Which Results in Reduced Gene Expression* , 1996, The Journal of Biological Chemistry.

[35]  F. Lupu,et al.  Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Stromelysin-1 (MMP-3) Gene Inactivation , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[36]  M E Safar,et al.  Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. , 1999, Journal of hypertension.

[37]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[38]  T. Waddell,et al.  Carotid Pressure Is a Better Predictor of Coronary Artery Disease Severity Than Brachial Pressure , 2001, Hypertension.

[39]  S. Laurent,et al.  Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients: A Longitudinal Study , 2002, Hypertension.

[40]  P. Talmud,et al.  The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. , 1998, Atherosclerosis.

[41]  M. Safar,et al.  Pressure-independent contribution of sodium to large artery structure and function in hypertension. , 2000, Cardiovascular research.

[42]  R. Zulli,et al.  Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. , 1996, Hypertension.

[43]  A. Gnasso,et al.  Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. , 2000, Arteriosclerosis, thrombosis, and vascular biology.